Working with FDA: Biological Products and Clinical Development

May 14, 2007: Bethesda, Maryland

Food and Drug Administration, National Institutes of Health, National Cancer Institute Food and Drug AdministrationNational Institutes of HealthNational Cancer Institute

Meeting Agenda (MS Word document)

Speaker Information (MS Word document)

SMIL and PowerPoint Presentations

Welcome

Introductions

Practical and Organizational Issues for PI-Initiated Projects

Regulatory Requirements and Recommendations

Major Clinical and Scientific Components of the IND

Preclinical and Nonclinical Testing

Clinical Trials

Manufacturing

Case Studies: The Good, the Bad, and the Ugly

Bibliography

Supplementary Materials

 

 FDANational Cancer Institute

U.S. Department of Health and Human Services, National Institutes of Health